Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, ...
Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
Business Insider6d
Bronstein, Gewirtz & Grossman, LLC Is Investigating Corcept Therapeutics Incorporated (CORT) And Encourages Stockholders to Connect
Investigation Details In August 2020, Teva Pharmaceutical Industries Limited ("Teva") received approval from the U.S. Food ...
sharewise4d
Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance
Teva Pharmaceutical Industries Ltd. continues to strengthen its global market position through strategic access initiatives ...
The Pharma Letter4d
Teva resumes scarce epilepsy drug Finlepsin retard deliveries to Russia
Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin ...
Teva, Medincell announce FDA acceptance of sNDA for Uzedy
Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, and Medincell announced that the supplemental New Drug ...
The Pharma Letter6d
FDA accepts Teva and Medincell’s Uzedy sNDA
Israel-headquartered Teva Pharmaceutical Industries’ US subsidiary and France’s and Medincell announced that the supplemental ...
Global High Potency Active Pharmaceutical Ingredients Market to Surpass USD 45 Billion Mark by 2032 | DelveInsight
DelveInsight's High Potency Active Pharmaceutical Ingredients Market Insights report provides the current and forecast market ...
Mylan's Copaxone Suit Against Teva Should Survive, Judge Says
Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...